These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 35839732)
41. Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma. Dehner CA; Armstrong AE; Yohe M; Shern JF; Hirbe AC Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680895 [TBL] [Abstract][Full Text] [Related]
42. Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk Stratification. de Traux de Wardin H; Xu B; Dermawan JK; Smith MH; Wolden SL; Antonescu CR; Wexler LH JCO Precis Oncol; 2023 Jun; 7(1):e2200705. PubMed ID: 37315267 [TBL] [Abstract][Full Text] [Related]
43. Molecular diagnostics in the management of rhabdomyosarcoma. Arnold MA; Barr FG Expert Rev Mol Diagn; 2017 Feb; 17(2):189-194. PubMed ID: 28058850 [TBL] [Abstract][Full Text] [Related]
44. An Integrative Morphologic and Molecular Approach for Diagnosis and Subclassification of Rhabdomyosarcoma. Fan R; Parham DM; Wang LL Arch Pathol Lab Med; 2022 Aug; 146(8):953-959. PubMed ID: 35051261 [TBL] [Abstract][Full Text] [Related]
45. Childhood rhabdomyosarcoma: new insight on biology and treatment. Huh WW; Skapek SX Curr Oncol Rep; 2010 Nov; 12(6):402-10. PubMed ID: 20820958 [TBL] [Abstract][Full Text] [Related]
46. Rhabdomyosarcoma in children - current pathologic and molecular classification. Dziuba I; Kurzawa P; Dopierała M; Larque AB; Januszkiewicz-Lewandowska D Pol J Pathol; 2018; 69(1):20-32. PubMed ID: 29895123 [TBL] [Abstract][Full Text] [Related]
47. SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma. Karanian M; Pissaloux D; Gomez-Brouchet A; Chevenet C; Le Loarer F; Fernandez C; Minard V; Corradini N; Castex MP; Duc-Gallet A; Blay JY; Tirode F Am J Surg Pathol; 2020 May; 44(5):607-616. PubMed ID: 32187044 [TBL] [Abstract][Full Text] [Related]
49. Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma. Szuhai K; de Jong D; Leung WY; Fletcher CD; Hogendoorn PC J Pathol; 2014 Feb; 232(3):300-7. PubMed ID: 24272621 [TBL] [Abstract][Full Text] [Related]
50. Perianal/perineal rhabdomyosarcoma: Results of the SIOP MMT 95, Italian RMS 96, and EpSSG RMS 2005 studies. Rogers T; Zanetti I; Coppadoro B; Martelli H; Jenney M; Minard-Colin V; Terwisscha van Scheltinga SEJ; Skerritt C; Fajardo RD; Guérin F; Kelsey A; Merks JHM; Mandeville H; Guillén G; Glosli H; De Corti F; Bisogno G Pediatr Blood Cancer; 2022 Sep; 69(9):e29739. PubMed ID: 35460336 [TBL] [Abstract][Full Text] [Related]
51. The expanding morphological and genetic spectrum of MYOD1-mutant spindle cell/sclerosing rhabdomyosarcomas: a clinicopathological and molecular comparison of mutated and non-mutated cases. Tsai JW; ChangChien YC; Lee JC; Kao YC; Li WS; Liang CW; Liao IC; Chang YM; Wang JC; Tsao CF; Yu SC; Huang HY Histopathology; 2019 May; 74(6):933-943. PubMed ID: 30604891 [TBL] [Abstract][Full Text] [Related]
52. Detection and clinical significance of bone marrow involvement in patients with rhabdomyosarcoma. Krsková L; Mrhalová M; Hilská I; Sumerauer D; Drahokoupilová E; Múdry P; Kodet R Virchows Arch; 2010 May; 456(5):463-72. PubMed ID: 20405298 [TBL] [Abstract][Full Text] [Related]
53. Treatment and outcome of patients with localized intrathoracic and chest wall rhabdomyosarcoma: a report of the Cooperative Weichteilsarkom Studiengruppe (CWS). Fuchs J; Urla C; Sparber-Sauer M; Schuck A; Leuschner I; Klingebiel T; Blumenstock G; Seitz G; Koscielniak E J Cancer Res Clin Oncol; 2018 May; 144(5):925-934. PubMed ID: 29464349 [TBL] [Abstract][Full Text] [Related]
54. Spindle cell rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of seven new cases. Mentzel T; Kuhnen C Virchows Arch; 2006 Nov; 449(5):554-60. PubMed ID: 17013628 [TBL] [Abstract][Full Text] [Related]
56. Building the bridge between rhabdomyosarcoma in children, adolescents and young adults: the road ahead. Van Gaal JC; De Bont ES; Kaal SE; Versleijen-Jonkers Y; van der Graaf WT Crit Rev Oncol Hematol; 2012 Jun; 82(3):259-79. PubMed ID: 21802959 [TBL] [Abstract][Full Text] [Related]
57. Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma. Kim J; Light N; Subasri V; Young EL; Wegman-Ostrosky T; Barkauskas DA; Hall D; Lupo PJ; Patidar R; Maese LD; Jones K; Wang M; Tavtigian SV; Wu D; Shlien A; Telfer F; Goldenberg A; Skapek SX; Wei JS; Wen X; Catchpoole D; Hawkins DS; Schiffman JD; Khan J; Malkin D; Stewart DR JCO Precis Oncol; 2021; 5():. PubMed ID: 34095712 [TBL] [Abstract][Full Text] [Related]
58. [Spindle cell rhabdomyosarcoma in adults: a new entity in the spectrum of malignant mesenchymal tumors of soft tissues]. Mentzel T Pathologe; 2010 Mar; 31(2):91-6. PubMed ID: 19997735 [TBL] [Abstract][Full Text] [Related]
59. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children]. Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063 [No Abstract] [Full Text] [Related]
60. Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study. Ferrari A; Chisholm JC; Jenney M; Minard-Colin V; Orbach D; Casanova M; Guillen G; Glosli H; van Rijn RR; Schoot RA; Cameron AL; Rogers T; Alaggio R; Ben-Arush M; Mandeville HC; Devalck C; Defachelles AS; Coppadoro B; Bisogno G; Merks JHM Lancet Child Adolesc Health; 2022 Aug; 6(8):545-554. PubMed ID: 35690071 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]